11 Considerations for Tapering Biologic Therapy in Inflammatory Arthritis

Jan 07, 2020

In a review published last month in Autoimmunity Reviews, British researchers outline factors physicians should consider when contemplating tapering biologic therapies in patients with inflammatory arthritis. How best to wean patients from biologic therapy is an issue that comes up more frequently these days as patients increasingly achieve remission or low disease activity. In this slideshow, we highlight considerations physicians may want to consider in treating these patients.

In a review published last month in Autoimmunity Reviews, Christopher Edwards, M.D., of the University Hospital Southamptom, United Kingdom, outlines factors physicians should consider when contemplating tapering biologic therapies in patients with inflammatory arthritis. How best to wean patients from biologic therapy is an issue that comes up more frequently these days as patients increasingly achieve remission or low disease activity. In this slideshow, we highlight the considerations Dr. Edwards and his colleagues suggest be made in treating patients with inflammatory arthritis.REFERENCE:  Edwards CJ, Galeazzi M, Bellinvia S, Ringer A, Dimitroulas T, Kitas G. "Can we wean patients with inflammatory arthritis from biological therapies?" Autoimmun Rev. 2019 Dec;18(12):102399. doi: 10.1016/j.autrev.2019.102399. Epub 2019 Oct 19.